RxDoctor Payments Data

Ronald Walters, MD

Internal Medicine · Pinehurst, NCNPI 1699798157

Payments from drug & device makers

$190in general payments, 2019–2025

Across 11 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$62
  • AbbVie$38
  • Esperion Therapeutics, Inc.$38
  • Exact Sciences$21
  • Lilly USA, LLC$17
  • Paratek Pharmaceuticals, Inc.$13

What the payments were for

  • Food & beverage$190100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$190 in reported general payments places this provider in the 50th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$161,877
Medicare patients
316
Services billed
2,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban240$145,961
OzempicSemaglutide91$143,398
Repatha SureclickEvolocumab95$70,660
TrulicityDulaglutide17$30,104
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$28,890
ProliaDenosumab16$27,008
JardianceEmpagliflozin19$19,672
XareltoRivaroxaban16$13,113
MounjaroTirzepatide11$11,520
Repatha SyringeEvolocumab13$11,385
Breo ElliptaFluticasone/Vilanterol27$10,473
TradjentaLinagliptin15$10,037
LivaloPitavastatin Calcium19$8,157
Atorvastatin Calcium636$6,109
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,361

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$143,39891 claims
Lilly USA, LLCTrulicity, Mounjaro$17$41,62428 claims
AbbVieSynthroid$38$4,75763 claims
Esperion Therapeutics, Inc.Nexlizet$38$4,17911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,302 internal medicine providers in North Carolina.

Other internal medicine in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →